← FDA Drug Approvals (Drugs@FDA)
JESDUVROQ
NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 2023-02-01
Drug application
- FDA Application #
NDA216951- Application type
- New Drug Application
- Brand name
- JESDUVROQ
- Generic name
- DAPRODUSTAT
- Active ingredients
- DAPRODUSTAT
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- GLAXOSMITHKLINE
- Manufacturer
- GlaxoSmithKline LLC
- First approval
- 2023-02-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown